National Healthcare Corp

National Healthcare Corp(NHC)股票分析

$235.600

-11.733 (-4.98%)收盘时

Loading chart…
最高
248.200
开盘
247.940
成交量加权均价
239.16
成交量
116.55K
市值
1.66B
最低
233.680
成交额
27.87M
企业价值/息税折旧摊销前利润(TTM)
0.00

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies.

AI 分析 of National Healthcare Corp (NHC)

买入

National Healthcare Corp is a good buy right now due to its impressive earnings growth and strong revenue momentum. The current price is $242.82, with a forward P/E ratio of 9.89, indicating that the stock is undervalued relative to its earnings potential. Additionally, the company reported a gross margin of 37.98% in Q2 2026, showcasing its operational efficiency. However, the RSI is at 73.92, suggesting that the stock may be overbought in the short term, which is a risk to consider.

估值指标

National Healthcare Corp(NHC)当前预期市盈率为 9.89,5 年平均预期市盈率为 1.69。

预期市盈率

严重高估
5 年均值 P/E
1.69
当前P/E
9.89
高估
5.59
低估
-2.20

预期 EV/EBITDA

严重低估
5 年均值 EV/EBITDA
0.00
当前EV/EBITDA
0.00
高估
0.00
低估
0.00

预期市销率

严重低估
5 年均值 P/S
0.00
当前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 对 NHC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%NHC

$104.57

情景价格

基

基准

基准 · 50%NHC

$86.97

情景价格

悲

悲观

悲观 · 25%NHC

$67.53

情景价格

持有 NHC 的大户

W

Washington H. Soul Pattinson and Company Limited

+ 持有NHCPEN

-14.08%

3个月收益率

事件时间线

2026-08-07 (ET)

07:30:00

Q2 Revenue Reaches $408M vs $375M Last Year

2026-05-08 (ET)

07:11:00

Q1 Revenue Reaches $381.8M

2026-05-07 (ET)

16:50:00

National HealthCare Corporation Increases Quarterly Dividend to $0.67

2026-04-21 (ET)

16:50:00

National HealthCare to Acquire 32 Nursing Facilities for $560M

2025-05-08 (ET)

16:45:53

National Healthcare announces 4.9% increase in quarterly common dividend to 64c

资讯

NHC 常见问题 —— 由 Alphio AI 解答

National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages approximately 80 skilled nursing facilities with 10,323 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. It operates in the Healthcare sector (SERVICES-SKILLED NURSING CARE FACILITIES industry).

National Healthcare Corp is a good buy right now due to its impressive earnings growth and strong revenue momentum. The current price is $242.82, with a forward P/E ratio of 9.89, indicating that the stock is undervalued relative to its earnings potential. Additionally, the company reported a gross margin of 37.98% in Q2 2026, showcasing its operational efficiency. However, the RSI is at 73.92, suggesting that the stock may be overbought in the short term, which is a risk to consider.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易